Clascoterone Solution clinical trials

A 6-Month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone (Cortexolone 17α-Propionate) Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-Month Single-Blind Treatment with Clascoterone or Vehicle BID Solution (SCALP 2)

This study is testing a new gel (Clascoterone solution) for men with thinning hair (male-pattern baldness). We want to see if it helps hair grow and if it's safe to use over 6 months, comparing it to a dummy gel.